COVID-19 Situation Report, n.24 (7 September 2020)

Abstract

PAHO continued to collaborate with its partners within the Region and across the globe to deliver technical cooperation, evidence-based guidance, and recommendations, and to advocate for the Americas on the global stage. PAHO’s regional IMST also provided support and strategic guidance to countries’ IMSTs as they coordinate and monitor their national response activities. Regulatory frameworks and requirements Health technology assessments (HTAs) are invaluable guidance for health authorities in the use of technologies relevant to the COVID-19 pandemic. The Regional Database of HTA Reports of the Americas (BRISA) now has 264 reports available in its COVID-19 section. PAHO continued to work with its Member States to provide guidance on the use of in vitro diagnostics (IVDs) and other regulatory aspects, considering authorizations from WHO’s Emergency Use Listing procedure (EUL) and recommendations from eight NRAs from around the globe. PAHO continued to maintain a list of 67 prioritized IVDs for proprietary and open platforms. SITUATION IN NUMBERS IN THE AMERICAS as of 07 September: 14,193,356 Confirmed cases*, 494,145 Deaths*, 54 Countries / areas / territories counted for epidemiological purposes.